CN105308037A - 三唑化合物及其作为γ分泌酶调节剂的用途 - Google Patents
三唑化合物及其作为γ分泌酶调节剂的用途 Download PDFInfo
- Publication number
- CN105308037A CN105308037A CN201480031612.5A CN201480031612A CN105308037A CN 105308037 A CN105308037 A CN 105308037A CN 201480031612 A CN201480031612 A CN 201480031612A CN 105308037 A CN105308037 A CN 105308037A
- Authority
- CN
- China
- Prior art keywords
- alkyl
- phenyl
- group
- methyl
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C*[n](c(C)n1)nc1Br Chemical compound C*[n](c(C)n1)nc1Br 0.000 description 3
- FRAKFBWDPXYIQO-UHFFFAOYSA-N Brc1nc(Br)n[nH]1 Chemical compound Brc1nc(Br)n[nH]1 FRAKFBWDPXYIQO-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (20)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE1350683 | 2013-06-04 | ||
SE1350683-7 | 2013-06-04 | ||
PCT/EP2014/061498 WO2014195321A1 (en) | 2013-06-04 | 2014-06-03 | Triazole compounds and their use as gamma secretase modulators |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105308037A true CN105308037A (zh) | 2016-02-03 |
CN105308037B CN105308037B (zh) | 2017-09-19 |
Family
ID=50884402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201480031612.5A Expired - Fee Related CN105308037B (zh) | 2013-06-04 | 2014-06-03 | 三唑化合物及其作为γ分泌酶调节剂的用途 |
Country Status (5)
Country | Link |
---|---|
US (1) | US9611254B2 (zh) |
EP (1) | EP3004081B1 (zh) |
JP (1) | JP6368776B2 (zh) |
CN (1) | CN105308037B (zh) |
WO (1) | WO2014195321A1 (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JOP20200117A1 (ar) | 2014-10-30 | 2017-06-16 | Janssen Pharmaceutica Nv | كحولات ثلاثي فلوروميثيل كمُعدلات للمستقبل النووي جاما تي المرتبط بحمض الريتيونَويك ROR?t |
WO2016069976A1 (en) | 2014-10-30 | 2016-05-06 | Janssen Pharmaceutica Nv | THIAZOLES AS MODULATORS OF RORyt |
TW201803869A (zh) | 2016-04-27 | 2018-02-01 | 健生藥品公司 | 作為RORγT調節劑之6-胺基吡啶-3-基噻唑 |
CA3103771A1 (en) | 2018-06-18 | 2019-12-26 | Janssen Pharmaceutica Nv | 6-aminopyridin-3-yl pyrazoles as modulators of roryt |
JP2021528405A (ja) | 2018-06-18 | 2021-10-21 | ヤンセン ファーマシューティカ エヌ.ベー. | RORγtのモジュレータとしてのアミド置換チアゾール |
WO2019244002A1 (en) | 2018-06-18 | 2019-12-26 | Janssen Pharmaceutica Nv | Pyridinyl pyrazoles as modulators of roryt |
CA3103770A1 (en) | 2018-06-18 | 2019-12-26 | Janssen Pharmaceutica Nv | Phenyl and pyridinyl substituted imidazoles as modulators of roryt |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008156580A1 (en) * | 2007-06-13 | 2008-12-24 | Merck & Co., Inc. | Triazole derivatives for treating alzheimer's disease and related conditions |
WO2010059393A1 (en) * | 2008-10-30 | 2010-05-27 | Janssen Pharmaceutica Nv | Serotonin receptor modulators |
WO2011092272A1 (en) * | 2010-02-01 | 2011-08-04 | F. Hoffmann-La Roche Ag | Gamma secretase modulaters |
WO2012126984A1 (en) * | 2011-03-24 | 2012-09-27 | Janssen Pharmaceuticals, Inc. | Novel substituted triazolyl piperazine and triazolyl piperidine derivatives as gamma secretase modulators |
CN102906083A (zh) * | 2010-01-15 | 2013-01-30 | 杨森制药公司 | 作为γ分泌酶调节剂的新的取代的三唑衍生物 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20030312A1 (it) | 2003-02-21 | 2004-08-22 | Chiesi Farma Spa | Derivati di acidi 2-fenil-2-alchil-acetici per il trattamento della malattia di alzheimer. |
ATE464048T1 (de) | 2003-08-07 | 2010-04-15 | Merck Sharp & Dohme | Behandlung von alzheimer-krankheit und verwandten zuständen |
DE602004023762D1 (de) | 2003-12-03 | 2009-12-03 | Merck Sharp & Dohme | Für die behandlung von alzheimer-krankheit und ähnlichen leiden geeignete 1-alkyl-3-thiosubstituierte indol-2-alkinsäuren |
KR101128065B1 (ko) | 2004-05-26 | 2012-04-12 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 신나미드 화합물 |
WO2007125364A1 (en) | 2006-04-26 | 2007-11-08 | Merck Sharp & Dohme Limited | Piperidines and related compounds for treatment of alzheimer’s disease |
EP2019093A4 (en) | 2006-05-19 | 2011-02-23 | Eisai R&D Man Co Ltd | CINEMA ACID AMID DERIVATIVE FROM THE UREA TYPE |
JP2009184924A (ja) | 2006-05-31 | 2009-08-20 | Eisai R & D Management Co Ltd | 生物学的試薬用化合物 |
AU2008214372A1 (en) | 2007-02-08 | 2008-08-14 | Merck Sharp & Dohme Corp. | Therapeutic agents |
WO2008100412A1 (en) | 2007-02-12 | 2008-08-21 | Merck & Co., Inc. | Piperidine derivatives |
EP2121633A2 (en) | 2007-02-12 | 2009-11-25 | Merck & Co., Inc. | Piperazine derivatives for treatment of ad and related conditions |
JP2010535762A (ja) | 2007-08-06 | 2010-11-25 | シェーリング コーポレイション | ガンマセクレターゼモジュレーター |
KR101244517B1 (ko) | 2008-01-11 | 2013-03-18 | 에프. 호프만-라 로슈 아게 | 아밀로이드 베타에 대한 조절제 |
CA2713716A1 (en) | 2008-02-22 | 2009-08-27 | F. Hoffmann-La Roche Ag | Modulators for amyloid beta |
BRPI0921317A2 (pt) | 2008-11-06 | 2017-06-06 | Astrazeneca Ab | composto, composição farmacêutica, e, método para tratar ou prevenir uma patologia relacionada com abeta em um mamífero |
KR101293421B1 (ko) | 2008-11-10 | 2013-08-05 | 에프. 호프만-라 로슈 아게 | 헤테로사이클릭 감마 분비효소 조절제 |
TW201030002A (en) | 2009-01-16 | 2010-08-16 | Bristol Myers Squibb Co | Bicyclic compounds for the reduction of beta-amyloid production |
JP5654001B2 (ja) * | 2009-04-29 | 2015-01-14 | グラクソ グループ リミテッドGlaxo Group Limited | P2X7調節因子としての5,6,7,8−テトラヒドロ[1,2,4]トリアゾロ[4,3−a]ピラジン誘導体 |
UY32622A (es) | 2009-05-12 | 2010-12-31 | Astrazeneca Ab | Nuevos compuestos para el tratamiento de patologías relacionadas con ab(beta) |
EP2454239B1 (en) | 2009-07-15 | 2014-08-13 | Janssen Pharmaceuticals Inc. | Substituted triazole and imidazole derivatives as gamma secretase modulators |
TWI468402B (zh) | 2009-07-31 | 2015-01-11 | 必治妥美雅史谷比公司 | 降低β-類澱粉生成之化合物 |
TW201206946A (en) | 2010-07-15 | 2012-02-16 | Bristol Myers Squibb Co | Compounds for the reduction of beta-amyloid production |
-
2014
- 2014-06-03 WO PCT/EP2014/061498 patent/WO2014195321A1/en active Application Filing
- 2014-06-03 US US14/895,512 patent/US9611254B2/en active Active
- 2014-06-03 CN CN201480031612.5A patent/CN105308037B/zh not_active Expired - Fee Related
- 2014-06-03 EP EP14727827.9A patent/EP3004081B1/en not_active Not-in-force
- 2014-06-03 JP JP2016517273A patent/JP6368776B2/ja not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008156580A1 (en) * | 2007-06-13 | 2008-12-24 | Merck & Co., Inc. | Triazole derivatives for treating alzheimer's disease and related conditions |
WO2010059393A1 (en) * | 2008-10-30 | 2010-05-27 | Janssen Pharmaceutica Nv | Serotonin receptor modulators |
CN102906083A (zh) * | 2010-01-15 | 2013-01-30 | 杨森制药公司 | 作为γ分泌酶调节剂的新的取代的三唑衍生物 |
WO2011092272A1 (en) * | 2010-02-01 | 2011-08-04 | F. Hoffmann-La Roche Ag | Gamma secretase modulaters |
WO2012126984A1 (en) * | 2011-03-24 | 2012-09-27 | Janssen Pharmaceuticals, Inc. | Novel substituted triazolyl piperazine and triazolyl piperidine derivatives as gamma secretase modulators |
Also Published As
Publication number | Publication date |
---|---|
US20160122326A1 (en) | 2016-05-05 |
JP2016520635A (ja) | 2016-07-14 |
CN105308037B (zh) | 2017-09-19 |
JP6368776B2 (ja) | 2018-08-01 |
US9611254B2 (en) | 2017-04-04 |
WO2014195321A1 (en) | 2014-12-11 |
EP3004081A1 (en) | 2016-04-13 |
EP3004081B1 (en) | 2017-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105308037A (zh) | 三唑化合物及其作为γ分泌酶调节剂的用途 | |
JP4536517B2 (ja) | γ−セクレターゼ阻害剤としてのスルホンアミド、スルファメート及びスルファミド | |
TW591022B (en) | Tetrahydropyridino or piperidino heterocyclic derivatives | |
JP2006508092A (ja) | γ−セクレターゼの阻害のための環状スルファミド | |
US20080318943A1 (en) | Compounds and Uses Thereof - 848 | |
CN104169281B (zh) | 稠合的吡咯二甲酰胺和它们作为药物的用途 | |
CN102482264B (zh) | 2-氨甲酰基-7-哌嗪基-苯并呋喃衍生物774 | |
JP2010531292A (ja) | 化合物及びその使用 | |
EP2536711A1 (en) | 5-ht receptor modulators | |
EP3004079B1 (en) | Pyrimidine compounds and their use as gamma secretase modulators | |
TW201144295A (en) | Hemifumarate salt | |
CN107406445A (zh) | 新颖环丙苯并呋喃基吡啶并吡嗪二酮类 | |
CN105263922A (zh) | 三唑化合物及其作为γ分泌酶调节剂的用途 | |
TW200826939A (en) | N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide | |
JP2010514682A (ja) | 化合物及びその使用 | |
CN102083812A (zh) | 用于治疗疼痛、阿尔茨海默病和精神分裂症的毒蕈碱性受体激动剂 | |
EP1342723B1 (en) | Indole derivatives and use thereof in medicines | |
CN104337812A (zh) | 取代的杂芳基化合物及其使用方法和用途 | |
KR102603671B1 (ko) | 치환된 3-디알킬아미노메틸-피페리딘-4-일-벤즈아미드 및 이를 제조 및 사용하는 방법 | |
AU2014282977B2 (en) | 1-sulfonyl piperidine derivatives as modulators of prokineticin receptors | |
TW200940516A (en) | D2 receptor ligand | |
JP2010514683A (ja) | 化合物及びその使用 | |
CN101379042A (zh) | 作为gabaa受体调节剂的取代的噌啉衍生物及其合成方法 | |
JP2010514684A (ja) | 化合物及びその使用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191016 Address after: Solna, Sweden Patentee after: Akturam Real Estate Co.,Ltd. Address before: Swedish Suo de Jie Patentee before: ACTURUM LIFE SCIENCE AB Effective date of registration: 20191016 Address after: Hu Dinge, Sweden Patentee after: Aztec Pharmaceuticals Address before: Solna, Sweden Patentee before: Akturam Real Estate Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170919 |
|
CF01 | Termination of patent right due to non-payment of annual fee |